Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Akt1 T1135-p
GSK3B S1235-p
p70S6K T1135-p
SGK1 T1135-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

GSK3A T1695-p
GSK3B T1695-p
P70S6KB T1135-p
p70S6K T1135-p
Regulatory protein:
Akt1 T1135-p
HRas T1135-p , S1177-p
ILK T1135-p
mTOR T1135-p
PIK3CB T1135-p
Raptor T1135-p
RICTOR T1135-p
RICTOR T1135-p
Treatment:
amino_acids T1135-p
AZD1152 S1144-p
BI2536 S1090-p
BIO T1135-p , S1235-p
calyculin_A T1135-p
EGF T1135-p
ephrin_B1 Y1321-p
gefitinib T1135-p
IGF-1 T1135-p , S1177-p
imatinib T1135-p
insulin T1135-p
ischemia S21-p , S1177-p , S1302-p , S1385-p
LY294002 T1135-p
MG132_withdrawal S21-p
phorbol_ester T1135-p
PI-103 T1135-p
QLT0267 T1135-p
rapamycin T1133-p , T1135-p
SB216763 S1235-p
selumetinib S1035-p , T1135-p
serum T1135-p , S1177-p
sorbitol T1135-p , S1235-p
Su11274 T1135-p
TGF-beta T1135-p
thapsigargin S1235-p
Torin1 T1135-p
tunicamycin S1235-p
U0126 T1135-p
vemurafenib S1035-p
wortmannin T1135-p
Y27632 T1133-p , T1161-p , S1385-p , Y1386-p , S1388-p
ZM447439 S1144-p